Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and Plasma-Lyte 56 and Dextrose
Determining the interaction of Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and Plasma-Lyte 56 and Dextrose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: lvp solution with potassium
Brand name:
Synonyms: Dextrose and Electrolyte No 48
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Platinol
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Platinol-AQ
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Plavix
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Plazomicin
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Plazomicin Intravenous
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Plazomicin Sulfate
- Plasma-Lyte 56 and Dextrose-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Plasma-Lyte 56 and Dextrose-Kitabis Pak
- Plasma-Lyte 56 and Dextrose-Kitabis Pak inhalation
- Plasma-Lyte 56 and Dextrose-Klofensaid II
- Plasma-Lyte 56 and Dextrose-Klonopin
- Plasma-Lyte 56 and Dextrose-Klonopin Wafer